Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00293176 · ClinicalTrials.gov registry record · Phase 4
The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)
A Phase 4 study, sponsored by Eisai.
- Completed
- Registry status
- Phase 4
- Development phase
- 821
- Enrollment target
NCT00293176 is a Phase 4 study that has completed, run by Eisai. The registered enrollment target is 821 participants.
The verdict
NCT00293176, a Phase 4 study, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 821 participants
- Enrollment target
Study Summary
To investigate the efficacy and safety of donepezil in individuals with mild cognitive impairment on measures of cognition, global function and behavior.
Interventions
- DRUG Placebo
- DRUG Donepezil Hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 821 participants |
| Start Date | 2003-12 |
| Est. Completion | 2007-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00293176
The ClinicalTrials.gov registry entry for NCT00293176 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 821 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00293176 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00293176 about?
NCT00293176 is a clinical study titled "The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)". To investigate the efficacy and safety of donepezil in individuals with mild cognitive impairment on measures of cognition, global function and behavior.
What is the current status of trial NCT00293176?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 821 participants. The study started on 2003-12. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00293176?
The interventions under investigation include: Placebo (DRUG), Donepezil Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00293176?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.